ALAIN J TAYLON
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism OMAHA, NE NPI 1710023866
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NE Abbott Laboratories All categories
General Payments — all program years on this page
$6,775.54
- Category: General Payments
- Program years: PY2018–2023
- Record count: 605
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $143.00 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $143.00 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $66.48 | 4 |
| Horizon Pharma plc | $39.80 | 2 |
| Lilly USA, LLC | $22.58 | 1 |
| Amgen Inc. | $14.14 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1018859199 | Abbott Laboratories | $13.27 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1018860203 | Abbott Laboratories | $16.43 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1018866451 | Abbott Laboratories | $19.94 | 04/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1018905791 | Abbott Laboratories | $16.84 | 08/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1019780961 | Amgen Inc. | $14.14 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1031234019 | Lilly USA, LLC | $22.58 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 987082525 | Horizon Therapeutics plc | $22.67 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 987082527 | Horizon Therapeutics plc | $17.13 | 05/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.